[CLSTR]
< Back to all clusters
[HEALTH] · South Africa, Kenya, Egypt, Nigeria · 3 sources

started · updated

Part of situation: GLP-1 weight-loss drug market regulation in Africa (2 clusters)

South Africa regulates weight-loss drug compounding amid rising black market

GLP-1 drugs weight-loss medication counterfeit medicine South Africa pharmaceutical regulation

The market for GLP-1 medications, used for diabetes and obesity, is expanding across Africa, led by South Africa. Aspen reported that its local GLP-1 market reached approximately 170 million USD for the fiscal year ending June 2026. Novo Nordisk has also expanded its footprint, launching Ozempic and Wegovy in Kenya.

However, the surge in demand has triggered regulatory concerns in South Africa. The South African Pharmacy Council and the South African Health Products Regulatory Authority (SAHPRA) are revising guidelines to prevent pharmacies from acting as unauthorized small-scale manufacturers through large-scale compounding. Regulators warn that such practices increase the risk of counterfeit medicines.

Industry leaders, including the Pharmaceutical Task Group, have warned of a growing black market for unregistered weight-loss drugs. These products are reportedly being sold through informal channels, including social media influencers and gym instructors. Specifically, the experimental drug retatrutide is being sold openly despite lacking regulatory approval for safety or efficacy.

Entities

Aspen · Eli Lilly · Novo Nordisk · South African Health Products Regulatory Authority · South African Pharmacy Council

Claims

What the coverage asserts, and how many sources carry each claim.

  • [○ 1 SOURCE] The South African Pharmacy Council and SAHPRA are developing updated standards and guidelines for compounding medicines. srnnews.com
  • [○ 1 SOURCE] Novo Nordisk launched Ozempic and Wegovy in Kenya in September 2026. afrikactus.com
  • [○ 1 SOURCE] The experimental obesity drug retatrutide is being sold openly in South Africa despite not being approved by any regulator. www.thesouthafrican.com
  • [○ 1 SOURCE] The Pharmaceutical Task Group has called for law enforcement action against the sale of unregistered medicines. www.thesouthafrican.com
  • [○ 1 SOURCE] Aspen reported that the local GLP-1 market in South Africa nearly doubled to approximately 170 million USD for the fiscal year ending June 2026. afrikactus.com
  • [○ 1 SOURCE] The South African Pharmacy Council expressed concern regarding pharmacies acting as small-scale manufacturers through large-scale compounding. srnnews.com

Sources

Médicaments GLP-1 Afrique : prix et accès [afrikactus.com]
South Africa revises rules around customisation of weight-loss drugs [srnnews.com]
Illegal weight-loss drugs are being sold by influencers and hairdressers, drugmakers warn [www.thesouthafrican.com]